Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors
NCT07404176Phase 2Recruiting
- Sponsor
- Tata Memorial Hospital
- Start
- Mar 2026
- Primary completion
- Feb 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of terbium-161 dotatate in Neuroendocrine Neoplasm (NEN), sponsored by Tata Memorial Hospital. Started Mar 2026; status: recruiting.
02
Drugs
terbium-161 dotatate
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT07404176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07404176.